1. Home
  2. TAOP vs XBIO Comparison

TAOP vs XBIO Comparison

Compare TAOP & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAOP
  • XBIO
  • Stock Information
  • Founded
  • TAOP 1993
  • XBIO N/A
  • Country
  • TAOP China
  • XBIO United States
  • Employees
  • TAOP N/A
  • XBIO N/A
  • Industry
  • TAOP Computer Software: Prepackaged Software
  • XBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAOP Technology
  • XBIO Health Care
  • Exchange
  • TAOP Nasdaq
  • XBIO Nasdaq
  • Market Cap
  • TAOP 4.1M
  • XBIO 4.4M
  • IPO Year
  • TAOP N/A
  • XBIO N/A
  • Fundamental
  • Price
  • TAOP $3.15
  • XBIO $3.67
  • Analyst Decision
  • TAOP
  • XBIO Hold
  • Analyst Count
  • TAOP 0
  • XBIO 1
  • Target Price
  • TAOP N/A
  • XBIO N/A
  • AVG Volume (30 Days)
  • TAOP 160.6K
  • XBIO 16.0K
  • Earning Date
  • TAOP 12-08-2025
  • XBIO 11-11-2025
  • Dividend Yield
  • TAOP N/A
  • XBIO N/A
  • EPS Growth
  • TAOP N/A
  • XBIO N/A
  • EPS
  • TAOP N/A
  • XBIO N/A
  • Revenue
  • TAOP $36,196,786.00
  • XBIO $2,446,221.00
  • Revenue This Year
  • TAOP N/A
  • XBIO $1.99
  • Revenue Next Year
  • TAOP N/A
  • XBIO $20.00
  • P/E Ratio
  • TAOP N/A
  • XBIO N/A
  • Revenue Growth
  • TAOP N/A
  • XBIO N/A
  • 52 Week Low
  • TAOP $2.70
  • XBIO $2.20
  • 52 Week High
  • TAOP $25.50
  • XBIO $5.27
  • Technical
  • Relative Strength Index (RSI)
  • TAOP 47.15
  • XBIO 54.21
  • Support Level
  • TAOP $2.87
  • XBIO $2.81
  • Resistance Level
  • TAOP $3.23
  • XBIO $3.29
  • Average True Range (ATR)
  • TAOP 0.22
  • XBIO 0.20
  • MACD
  • TAOP 0.02
  • XBIO 0.00
  • Stochastic Oscillator
  • TAOP 64.41
  • XBIO 79.31

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: